首页> 外文期刊>Recent patents on regenerative medicine. >Recent Patents and Advances on Tag-Less Microfluidic Stem Cell Sorting Methods: Applications for Perinatal Stem Cell Isolation
【24h】

Recent Patents and Advances on Tag-Less Microfluidic Stem Cell Sorting Methods: Applications for Perinatal Stem Cell Isolation

机译:标签少的微流干细胞分选方法的最新专利和进展:围产期干细胞分离的应用

获取原文
获取原文并翻译 | 示例
           

摘要

Interest in stem cell separation and purification from easily accessible clinical specimens is booming due to the increase of cell therapy applications. The recovery of pluripotent or multipotent stem cells in human sources different from the embryo requires the use of effective methods of cell sorting/enrichment. Among these sources, perinatal tissues retain cells with pivotal stem cell features such as high self-renewal ability, wide differentiation potential and immuno-modulatory properties. In this perspective, methods exploiting cell biophysical differences in a less dependent process of identification based on specific markers are therefore promising. These methods allow cell isolation irrespective of the broad and diversified surface antigenic panel that usually limits the ability to easily distinguish cells as in the case of mes-enchymal stromal/stem cell separation. In addition, the use of non- or minimally invasive tag-less techniques might be a way to preserve stem cell features of the selected product and reduce regulatory issues related to their use in regenerative applications, hi this review, non-invasive cell sorting techniques based on microfluidic systems and relevant patents are described. In particular applications of emerging separation approach, Field-Flow Fractionation (FFF), for perinatal stem cell sorting are cited. Protocols and applications based on FFF-derived techniques are detailed.
机译:由于细胞治疗应用的增加,人们对从易于获取的临床标本中分离和纯化干细胞的兴趣日益浓厚。在不同于胚胎的人类来源中恢复多能或多能干细胞需要使用有效的细胞分选/富集方法。在这些来源中,围产期组织保留具有关键干细胞特征的细胞,例如高自我更新能力,广泛的分化潜能和免疫调节特性。在这种观点下,基于特异性标记物在较少依赖的鉴定过程中利用细胞生物物理差异的方法因此很有希望。这些方法允许进行细胞分离,而与宽泛和多样化的表面抗原组合无关,这通常限制了在间质间质/干细胞分离情况下容易区分细胞的能力。另外,使用无创或微创无标签技术可能是保留所选产品的干细胞特征并减少与其在再生应用中使用相关的监管问题的一种方法。在本文中,无创细胞分选技术基于微流体系统和相关专利的描述。在新兴分离方法的特殊应用中,列举了围产期干细胞分选的场流分级分离(FFF)。详细介绍了基于FFF的技术的协议和应用程序。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号